Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
Kwality Pharmaceuticals IPO is a fixed price issue of ₹6.21 crores. The issue is a combination of fresh issue of 0.02 crore shares aggregating to ₹0.8100 crores and offer for sale of 0.12 crore shares aggregating to ₹5.40 crores.
Kwality Pharmaceuticals IPO bidding started from Jun 30, 2016 and ended on Jul 8, 2016. The shares got listed on BSE SME on Jul 18, 2016.
Kwality Pharmaceuticals IPO price is ₹45.00 per share . The lot size for an application is 3,000. The minimum amount of investment required by an individual investor (retail) is ₹1,35,000 (3000 shares). The minimum lot size investment for HNI is 2 lots (6,000 shares), amounting to ₹2,70,000.
Oneview Corporate Advisors Pvt.Ltd. is the book running lead manager and Bigshare Services Pvt.Ltd. is the registrar of the issue. The market maker of the company is Guiness Securities Ltd..
Refer to Kwality Pharmaceuticals IPO RHP for detailed Information.
| IPO Date | June 30, 2016 to July 8, 2016 |
| Listing Date | July 18, 2016 |
| Face Value | ₹10 per share |
| Issue Price Band | |
| Issue Price Final | ₹45 per share |
| Lot Size | 3,000 Shares |
| Sale Type | Fresh Capital-cum-Offer for Sale |
| Total Issue Size | 13,80,000 shares (aggregating up to ₹6.21 Cr) |
| Reserved for Market Maker | 72,000 shares Guiness Securities Ltd. (aggregating up to ₹0.3240 Cr) |
| Fresh Issue (Ex Market Maker) | 1,08,000 shares (aggregating up to ₹0.4860 Cr) |
| Offer for Sale | 12,00,000 shares of ₹10 (aggregating up to ₹5.40 Cr) |
| Net Offered to Public | 13,08,000 shares (aggregating up to ₹5.89 Cr) |
| Issue Type | Fixed Price IPO |
| Listing At | BSE SME |
| Share Holding Pre Issue | 50,08,099 shares |
| Share Holding Post Issue | 51,88,099 shares |
Kwality Pharmaceuticals IPO offers total 13,80,000 shares. Out of which 6,54,000 (47.39%) allocated to NII, 6,54,000 (47.39%) allocated to RII.
| Investor Category | Shares Offered |
|---|---|
| Market Maker Shares Offered | 72,000 (5.22%) |
| NII (HNI) Shares Offered | 6,54,000 (47.39%) |
| Retail Shares Offered | 6,54,000 (47.39%) |
| Total Shares Offered | 13,80,000 (100.00%) |
Kwality Pharmaceuticals IPO opens on June 30, 2016, and closes on July 8, 2016.
| IPO Open Date | Thu, Jun 30, 2016 |
| IPO Close Date | Fri, Jul 8, 2016 |
| Tentative Listing Date | Mon, Jul 18, 2016 |
| Cut-off time for UPI mandate confirmation | 5 PM on Fri, Jul 8, 2016 |
Investors can bid for a minimum of 3,000 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 3,000 | ₹1,35,000 |
| Retail (Max) | 1 | 3,000 | ₹1,35,000 |
| HNI (Min) | 2 | 6,000 | ₹2,70,000 |
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
Incorporated in 1983, Kwality Pharmaceuticals Ltd (KPL) is engaged in the business of manufacturing of broad range of finished pharmaceutical formulations in a dosage form. Information in this paragraph is copied from chittorgarh.com.KPL is one of the leading manufacturer & exporters of pharmaceutical formulations in Liquid Orals, Dry Syrups, Tablets, Capsules, Sterile Powder for Injections and small volume injectable. The company has registered all its products in different Countries of Europe, Africa, Asia & CIS Countries.
According to the Company, it has the most modern & sophisticated plant, equipment's, technique and manpower and is working with new SCHEDULE M and W.H.O. norms and certified with GMP and WHO certificate.
The objects of the issue are:
1. Modernisation of Laboratory;
2. To meet the part of General Corporate Purpose;
3. To meet the expenses of the Offer.
[Dilip Davda] Only risk aver investors with cash surplus may consider long term investment. Read detail review...
| Listing Date | July 18, 2016 |
| BSE Script Code | 539997 |
| NSE Symbol | |
| ISIN | INE552U01010 |
| Final Issue Price | ₹45 per share |
| BSE Listing Group | MT |
| Price Details | BSE SME |
|---|---|
| Final Issue Price | ₹45.00 |
| Open | ₹45.00 |
| Low | ₹43.00 |
| High | ₹45.80 |
| Last Trade | ₹44.50 |
Kwality Pharmaceuticals Ltd.
Village
Nagkalan,
Majitha Road,
Amritsar, Punjab, 143601
Phone: +91- 0183-2774321-25
Email: cs@kwalitypharma.com
Website: http://www.kwalitypharma.com
Bigshare Services Pvt.Ltd.
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://ipo.bigshareonline.com/IPO_Status.html
Kwality Pharmaceuticals IPO is a SME IPO of 13,80,000 equity shares of the face value of ₹10 aggregating up to ₹6.21 Crores. The issue is priced at ₹45 per share. The minimum order quantity is 3000.
The IPO opens on June 30, 2016, and closes on July 8, 2016.
Bigshare Services Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE SME.
Zerodha customers can apply online in Kwality Pharmaceuticals IPO using UPI as a payment gateway. Zerodha customers can apply in Kwality Pharmaceuticals IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Kwality Pharmaceuticals IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Kwality Pharmaceuticals IPO opens on June 30, 2016 and closes on July 8, 2016.
Kwality Pharmaceuticals IPO lot size is 3000, and the minimum amount required for application is ₹1,35,000.
You can apply in Kwality Pharmaceuticals IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Kwality Pharmaceuticals IPO will be done on [.], and the allotted shares will be credited to your demat account by [.]. Check the Kwality Pharmaceuticals IPO allotment status.
The Kwality Pharmaceuticals IPO listing date is on Monday, July 18, 2016.
Useful Articles
RHP